Biogen/UCB’s Lupus Drug Shows Consistent Efficacy Across Endpoints, Over Time

Second Phase III Trial To Begin This Year

 
• By Mandy Jackson
  
Dapirolizumab pegol showed efficacy across various components of SLE disease activity (Shutterstock)

More from Clinical Trials

More from Scrip